SpyGlass Pharma, Inc. (SGP) News
Track canonical SquawkNews coverage tagged to SGP, SpyGlass Pharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
SpyGlass Pharma Acquires Advanced Vision Science Inc.
SpyGlass Pharma (NASDAQ:SGP) has acquired all outstanding shares of common stock of Advanced Vision Science, Inc. (AVS), a company that manufactures intraocular lenses.
EQUITY | Oct 01, 2026, 12:23 PM UTC
L
SGP: Innovative IOL delivers glaucoma therapy during cataract surgery, aiming for 2029 launch
A novel intraocular lens with integrated drug delivery targets a $13 billion market by simplifying glaucoma and cataract treatment in a single procedure, showing strong clinical efficacy and safety. Phase III trials are
NEWS | Sep 14, 2026, 07:42 PM UTC
L
SGP: Innovative lens delivers glaucoma therapy during cataract surgery, with launch targeted for 2029
A new intraocular lens with drug delivery aims to address glaucoma during cataract surgery, targeting a $13 billion market. Clinical trials show strong efficacy and safety, with regulatory and reimbursement pathways esta
NEWS | Sep 14, 2026, 07:30 PM UTC
L
SGP - SpyGlass Pharma to Participate in Upcoming Investor Conferences
SGP - SpyGlass Pharma to Participate in Upcoming Investor Conferences
EQUITY | Sep 02, 2026, 12:00 PM UTC
L
Market Wrap: Aussie shares end the week higher on amazing tech success
Market Wrap: Aussie shares end the week higher on amazing tech success
EQUITY | Aug 28, 2026, 09:36 AM UTC